文献综述(Review)

交界性可切除胰腺癌的研究进展

Published at: 2016年第25卷第3期

陈博滔 1 , 陈梅福 1
1 湖南师范大学第一附属医院/ 湖南省人民医院 肝胆外科,湖南 长沙 410005
通讯作者 梅福 陈 Email: chen_meifu@126.com
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2016.03.025
基金:

摘要

交界性可切除胰腺癌是介于可切除与不可切除胰腺癌之间的一个分期,其在技术上可获得根治性切除,但有较高风险出现阳性切缘的特点。笔者对最近几年关于交界性可切除胰腺癌预后评估及治疗方面的研究进展进行阐述和讨论。


Research progress of borderline resectable pancreatic cancer

Abstract

Borderline resectable pancreatic cancer (BRPC) is an intermediate stage between resectable and unresectable pancreatic cancer, characterized by having a chance to achieve radical resection technically but with high risk of positive surgical margin. In this paper, the authors address the recent advances in aspects of prognotic evaluation and treatment of this condition.


comments powered by Disqus

全文

引用

引用本文: 博滔 陈, 梅福 陈. 交界性可切除胰腺癌的研究进展[J]. 中国普通外科杂志, 2016, 25(3): 448-455.
Cite this article as: CHEN Botao, CHEN Meifu . Research progress of borderline resectable pancreatic cancer[J]. Chin J Gen Surg, 2016, 25(3): 448-455.